Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,

Published byClarence Marshall Modified over 6 years ago

Similar presentations

Presentation on theme: "A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,"— Presentation transcript:

1 A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD, Yuji Matsumura, MD, PhD, Nobuyuki Sato, MD, PhD, Hiroyuki Deguchi, MD, PhD, Hiroyuki Oizumi, MD, PhD, Motoyasu Sagawa, MD, PhD, Takao Tsushima, MD, PhD, Satomi Takahashi, MD, PhD, Jotaro Shibuya, MD, PhD, Masahide Hirose, MD, PhD, Takashi Kondo, MD, PhD  The Annals of Thoracic Surgery  Volume 98, Issue 1, Pages (July 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 CONSORT (consolidated standards of reporting trials) diagram. CWI = chest wall invasion; N2 = multiple mediastinal lymph node metastasis; PD = pleural dissemination; SCLC = small cell lung cancer; SRS = stereotactic radiosurgical treatment. Shaded boxes indicate patients undergoing complete resection of both primary and metastatic sites. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival of patients undergoing complete resection of both primary and metastatic sites. Patients undergoing complete resection of both primary tumor and metastasis had a 5-year survival of 44.7%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,"

Similar presentations

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Andranik Petrosyan, MD, Patrice Bergeron, MD 

Andranik Petrosyan, MD, Patrice Bergeron, MD 
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Similar presentations

Ads by Google